Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date (2011)
- Authors:
- Autor USP: VAINZOF, MARIZ - IB
- Unidade: IB
- Subjects: CÉLULAS-TRONCO; DOENÇAS NEUROMUSCULARES; DOENÇAS DEGENERATIVAS
- Language: Inglês
- Imprenta:
- ISBN: 978-953-307-632-4
- Source:
- Título do periódico: Embryonic stem cells - differentiation and pluripotent alternatives
- Volume/Número/Paginação/Ano: 506 p
-
ABNT
ALMEIDA, Camila F. e AYUB-GUERRIERI, Danielle e VAINZOF, Mariz. Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date. Embryonic stem cells - differentiation and pluripotent alternatives. Tradução . Rijeka: Instituto de Biociências, Universidade de São Paulo, 2011. . Disponível em: http://cdn.intechopen.com/pdfs/21360/InTech-Myogenic_differentiation_of_es_cells_for_therapies_in_neuromuscular_diseases_progress_to_date.pdf. Acesso em: 18 abr. 2024. -
APA
Almeida, C. F., Ayub-Guerrieri, D., & Vainzof, M. (2011). Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date. In Embryonic stem cells - differentiation and pluripotent alternatives. Rijeka: Instituto de Biociências, Universidade de São Paulo. Recuperado de http://cdn.intechopen.com/pdfs/21360/InTech-Myogenic_differentiation_of_es_cells_for_therapies_in_neuromuscular_diseases_progress_to_date.pdf -
NLM
Almeida CF, Ayub-Guerrieri D, Vainzof M. Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date [Internet]. In: Embryonic stem cells - differentiation and pluripotent alternatives. Rijeka: Instituto de Biociências, Universidade de São Paulo; 2011. [citado 2024 abr. 18 ] Available from: http://cdn.intechopen.com/pdfs/21360/InTech-Myogenic_differentiation_of_es_cells_for_therapies_in_neuromuscular_diseases_progress_to_date.pdf -
Vancouver
Almeida CF, Ayub-Guerrieri D, Vainzof M. Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date [Internet]. In: Embryonic stem cells - differentiation and pluripotent alternatives. Rijeka: Instituto de Biociências, Universidade de São Paulo; 2011. [citado 2024 abr. 18 ] Available from: http://cdn.intechopen.com/pdfs/21360/InTech-Myogenic_differentiation_of_es_cells_for_therapies_in_neuromuscular_diseases_progress_to_date.pdf - Immune-mediated rippling muscle disease in a patient with treated hypothyroidism. [Carta]
- Reduction of acethylcolinesterase activity in the brain of mdx mice
- Motor Chip: A comparative genomic hybridization microarray for copy-number mutations in 245 neuromuscular disorders
- Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies
- Striatum brain-derived neurotrophic factor levels are decreased in dystrophin-deficient mice
- Mitochondrial alterations in dynamin 2-related centronuclear myopathy
- Osteopontin expression during chronic and acute muscle injury
- Correction to: effects of low-intensity training on the brain and muscle in the congenital muscular dystrophy 1D model
- Myostatin expression in different mice models for neuromuscular disorders
- Mitochondrial respiratory chain and creatine kinase activities in mdx mouse brain
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas